Show simple item record

dc.contributor.authorOtt, German
dc.contributor.authorBalague-Ponz, Olga
dc.contributor.authorde Leval, Laurence
dc.contributor.authorde Jong, Daphne
dc.contributor.authorHasserjian, Robert Paul
dc.contributor.authorElenitoba-Johnson, Kojo S. J.
dc.date.accessioned2011-04-18T04:54:32Z
dc.date.issued2009
dc.identifier.citationOtt, German, Olga Balague-Ponz, Laurence de Leval, Daphne de Jong, Robert Paul Hasserjian, and Kojo S. J. Elenitoba-Johnson. 2009. Commentary on the WHO classification of tumors of lymphoid tissues (2008): Indolent B cell lymphomas. Journal of Hematopathology 2(2): 77-81.en_US
dc.identifier.issn1865-5785en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:4853429
dc.description.abstractThe 4th edition of the World Health Organization classification of tumors of hematopoietic and lymphoid tissues introduces many new items to the classification scheme of the so-called indolent B cell lymphomas. New proposed entities, such as splenic B cell lymphoma/leukemia, unclassifiable, splenic diffuse red pulp small B cell lymphoma, hairy cell leukemia variant, pediatric follicular lymphoma, and pediatric marginal zone lymphoma have been coined, and some definitions of established diseases, such as chronic lymphocytic leukemia or Waldenström’s macroglobulinemia have been revised. One aspect of major importance is the recent description of small clonal B cell populations, in part with a CLL phenotype, and their relationship to B-CLL. Some new subtypes or variants of follicular lymphoma with distinct clinicopathologic and/or molecular genetic characteristics have been described, including primary follicular lymphomas of the duodenum and pediatric follicular lymphomas. Furthermore, the impact of some probably early, or precursor lesions, such as follicular lymphoma in situ is discussed. Overall, we succinctly discuss the essential elements of the revisions made in the updated classification, and we identify potential opportunities for refinement of new or provisional categories in subsequent classifications.en_US
dc.language.isoen_USen_US
dc.publisherSpringer-Verlagen_US
dc.relation.isversionofdoi:10.1007/s12308-009-0037-9en_US
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725287/pdf/en_US
dash.licenseLAA
dc.subjectWHO classificationen_US
dc.subjectmalignant lymphomaen_US
dc.subjectindolenten_US
dc.subjectcommentaryen_US
dc.subjectlow gradeen_US
dc.titleCommentary on the WHO Classification of Tumors of Lymphoid Tissues (2008): Indolent B Cell Lymphomasen_US
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden_US
dc.relation.journalJournal of Hematopathologyen_US
dash.depositing.authorHasserjian, Robert Paul
dc.date.available2011-04-18T04:54:32Z
dash.affiliation.otherHMS^Pathologyen_US
dc.identifier.doi10.1007/s12308-009-0037-9*
dash.contributor.affiliatedHasserjian, Robert


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record